The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...

We believe Perrigo is in fine financial health. At the end of 2024, the company had roughly $560 million in cash and equivalents with about $3.3 billion in long-term debt. Its balance sheet was in a ...

After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price ...

Reckitt Benckiser is selling a majority stake in its home-care business, home to Air Wick fresheners and Cillit Bang cleaning products, to Advent International in a deal that values the whole unit at ...

In a testament to its enduring strength and adaptive strategy, Johnson & Johnson (NYSE: JNJ) today announced a strong ...

“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...

Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...

J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart.

If you look at the history of the S&P 500 ( ^GSPC -0.40%) index, dividend stocks have played a significant role in ...

New emerging life sciences hubs are gaining ground amid the market shift.

Naturally, dividend stocks, especially high-yielding ones, are alluring. That said, nothing in life is guaranteed, and ...